InsidersTradesSigma
EQL Pharma AB: management transactions · Finland · FIN-FSA
Browse the full management transaction log of EQL Pharma AB, a listed issuer based in Finland. Shares trade on FI FI, under the authority of FIN-FSA. Operating in the Health Care sector, EQL Pharma AB has published 8 public disclosures. Market capitalisation: €772.2m. The latest transaction was reported on 27 March 2026 (Sale). Among the most active insiders: Axel Schörling. The full history is free.
8
Insider Decl.
0
Thresholds
€100,159
3 ops.
Buy Volume
€118,679
2 ops.
Sell Volume
31Σ signal
Last declaration on 27 March 2026
Declarations8 total
24,066 shares@ €4.71440.015% mcap54.7% of flowAktieFI:A003X402-1
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
1,000 shares@ €6.14510.0008% mcap100.0% of flowAktieFI:A003S651-1
Ideal exit: 20 Jun 2026 (T+270)
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
667 shares@ €7.83030.0007% mcap100.0% of flowAktieFI:A003S329-1
289,155 shares0AktieFI:A003S161-1
38,370 shares0AktieFI:A003S141-2
345,642 shares0AktieFI:A003S140-1
100,000 shares@ €0.66060.0086% mcap31.8% of flowTeckningsoptionFI:A003R671-1
Ideal exit: 20 May 2026 (T+270)
3,650 shares@ €7.65830.0036% mcap13.5% of flowAktieFI:A003O464-1
Ideal exit: 10 Feb 2026 (T+270)
8 of 8 declarations